UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 103

Sortiert nach

Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure

BMJ (Online), 1994-10, Vol.309 (6958), p.833

1994

Volltextzugriff (PDF)

P067: Intérêt de l’utilisation d’un mélange de vitamines hydrosolubles chez les patients hémodialysés

Nutrition clinique et métabolisme, 2014-12, Vol.28, p.S103-S103

2014

Volltextzugriff (PDF)

Block randomized trial evidencing lower mortality with sevelamer compared with calcium phosphate binder in incident dialysis patients

Kidney international, 2008-02, Vol.73 (4), p.510-510

2008

Volltextzugriff (PDF)

Non-diabetic nephropathies and ACE inhibition

The Lancet (British edition), 1999-11, Vol.354 (9193), p.1905-1906

1999

Volltextzugriff (PDF)

The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial

Toxins, 2019-05, Vol.11 (5), p.279

2019

Volltextzugriff (PDF)

Renal and Hypertensive Complications of Extracorporeal Shock Wave Lithotripsy: Who Is at Risk?

Urologia internationalis, 1999-01, Vol.62 (4), p.195-200

1999

Volltextzugriff (PDF)

Calcium Metabolism, Plasma Parathyroid Hormone, and Calcitriol in Transient Hypertension of Pregnancy

American journal of hypertension, 1993-06, Vol.6 (6-Pt-1), p.522-527

1993

Volltextzugriff (PDF)

FP409SEVELAMER CARBONATE REDUCES PHOSPHATURIA BUT HAS NO EFFECT ON SERUM C-TERMINAL FIBROBLAST GROWTH FACTOR 23 LEVELS IN STAGE 3B/4 CKD PATIENTS : THE RESULTS OF A FRENCH, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROL, RANDOMIZED CLINICAL TRIAL

Nephrology, dialysis, transplantation, 2015-05, Vol.30 (suppl_3), p.iii207-iii207

2015

Volltextzugriff (PDF)

Sevelamer hydrochloride with or without alphacalcidol or higher dialysate calcium vs calcium carbonate in dialysis patients: an open‐label, randomized study

Nephrology, dialysis, transplantation, 2003-03, Vol.18 (3), p.582-589

2003

Volltextzugriff (PDF)

A ouabain-displacing factor in normal pregnancy, pregnancy-induced hypertension and pre-eclampsia

Clinical science (1979), 1988-03, Vol.74 (3), p.307

1988

Volltextzugriff (PDF)

Low parathyroid hormone levels and higher risk of hip fractures and mortality

American journal of kidney diseases, 2001-07, Vol.38 (1), p.222-223

2001

Volltextzugriff (PDF)

Pharmacokinetics of rilmenidine in patients with chronic renal insufficiency and in hemodialysis patients

The American journal of cardiology, 1994-12, Vol.74 (13), p.A43-A50

1994

Volltextzugriff (PDF)

Atrial natriuretic factor in pregnancy-induced hypertension and preeclampsia: increased plasma concentrations possibly explaining these hypovolemic states with paradoxical hyporeninism

American journal of hypertension, 1988-01, Vol.1 (1), p.16-21

1988

Volltextzugriff (PDF)

Fenofibrate increases creatininemia by increasing metabolic production of creatinine

Nephron (2015), 2002, Vol.92 (3), p.536

2002

Volltextzugriff (PDF)

Calcium antagonists and renal disease

Kidney international, 1999-12, Vol.56 (6), p.2311-2311

1999

Volltextzugriff (PDF)

Atrial natriuretic factor in pregnancy and pregnancy-induced hypertension

Canadian journal of physiology and pharmacology, 1991-10, Vol.69 (10), p.1601

1991

Volltextzugriff (PDF)

Place des nouveaux traitements de l'ostéodystrophie rénale : dérivés 1α-hydroxylés de la vitamine D « non hypercalcémiants », complexants non calciques, non magnésiens et non aluminiques des phosphates, et calcimimétiques

Immuno-analyse & biologie spécialisée, 2006-02, Vol.21 (1), p.9-32

2006

Volltextzugriff (PDF)

Renal Osteodystrophy in Dialysis Patients: Diagnosis and Treatment

Artificial organs, 1998-07, Vol.22 (7), p.530-557

1998

Volltextzugriff (PDF)

Bone mineral density directly correlates with elevated serum leptin in haemodialysis patients

Nephrology, dialysis, transplantation, 2003-09, Vol.18 (9), p.1882-1890

2003

Volltextzugriff (PDF)

Low doses of calcitriol or calcium carbonate for the prevention of hyperparathyroidism in predialysis patients?

Nephrology, dialysis, transplantation, 1996-07, Vol.11 (7), p.1493-1494

1996

Volltextzugriff (PDF)

Is oral intermittent calcitriol more effective than daily calcitriol therapy in suppressing overt secondary hyperparathyroidism in predialysis patients?

Nephrology, dialysis, transplantation, 1997-02, Vol.12 (2), p.365-367b

1997

Volltextzugriff (PDF)

Optimal plasma concentrations of intact parathyroid hormone in predialysis patients

Nephrology, dialysis, transplantation, 1995-12, Vol.10 (12), p.2376-2377

1995

Volltextzugriff (PDF)

Improvement of severe secondary hyperparathyroidism in dialysis patients by intravenous 1 alpha(OH) vitamin D3, oral CaCO3 and low dialysate calcium

Kidney international. Supplement, 1993-06, Vol.41, p.S121

1993

Volltextzugriff (PDF)

Cinacalcet and vascular calcifications induced by calcitriol

Nephrology, dialysis, transplantation, 2006-02, Vol.21 (2), p.551-552

2006

Volltextzugriff (PDF)

How do calcimimetics fit into the management of parathyroid hormone, calcium, and phosphate disturbances in dialysis patients?

Seminars in dialysis, 2005-05, Vol.18 (3), p.226-238

2005

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(64)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(62)
Female
(33)
Life Sciences & Biomedicine
(33)
Science & Technology
(33)
Urology & Nephrology
(24)
Adult
(23)
Male
(22)
Middle Aged
(20)
Aged
(15)
Biological And Medical Sciences
(14)
Medical Sciences
(13)
Renal Dialysis
(13)
Transplantation
(11)
Parathyroid Hormone - Blood
(9)
Animals
(8)
Kidney Failure, Chronic - Complications
(8)
Phosphates - Blood
(8)
Blood Pressure
(7)
Calcium Carbonate - Administration & Dosage
(7)
Risk Factors
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure

P067: Intérêt de l’utilisation d’un mélange de vitamines hydrosolubles chez les patients hémodialysés

Block randomized trial evidencing lower mortality with sevelamer compared with calcium phosphate binder in incident dialysis patients

Non-diabetic nephropathies and ACE inhibition

The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial

Renal and Hypertensive Complications of Extracorporeal Shock Wave Lithotripsy: Who Is at Risk?

Calcium Metabolism, Plasma Parathyroid Hormone, and Calcitriol in Transient Hypertension of Pregnancy

FP409SEVELAMER CARBONATE REDUCES PHOSPHATURIA BUT HAS NO EFFECT ON SERUM C-TERMINAL FIBROBLAST GROWTH FACTOR 23 LEVELS IN STAGE 3B/4 CKD PATIENTS : THE RESULTS OF A FRENCH, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROL, RANDOMIZED CLINICAL TRIAL

Sevelamer hydrochloride with or without alphacalcidol or higher dialysate calcium vs calcium carbonate in dialysis patients: an open‐label, randomized study

A ouabain-displacing factor in normal pregnancy, pregnancy-induced hypertension and pre-eclampsia

Low parathyroid hormone levels and higher risk of hip fractures and mortality

Pharmacokinetics of rilmenidine in patients with chronic renal insufficiency and in hemodialysis patients

Atrial natriuretic factor in pregnancy-induced hypertension and preeclampsia: increased plasma concentrations possibly explaining these hypovolemic states with paradoxical hyporeninism

Fenofibrate increases creatininemia by increasing metabolic production of creatinine

Calcium antagonists and renal disease

Atrial natriuretic factor in pregnancy and pregnancy-induced hypertension

Place des nouveaux traitements de l'ostéodystrophie rénale : dérivés 1α-hydroxylés de la vitamine D « non hypercalcémiants », complexants non calciques, non magnésiens et non aluminiques des phosphates, et calcimimétiques

Renal Osteodystrophy in Dialysis Patients: Diagnosis and Treatment

Bone mineral density directly correlates with elevated serum leptin in haemodialysis patients

Low doses of calcitriol or calcium carbonate for the prevention of hyperparathyroidism in predialysis patients?

Is oral intermittent calcitriol more effective than daily calcitriol therapy in suppressing overt secondary hyperparathyroidism in predialysis patients?

Optimal plasma concentrations of intact parathyroid hormone in predialysis patients

Improvement of severe secondary hyperparathyroidism in dialysis patients by intravenous 1 alpha(OH) vitamin D3, oral CaCO3 and low dialysate calcium

Cinacalcet and vascular calcifications induced by calcitriol

How do calcimimetics fit into the management of parathyroid hormone, calcium, and phosphate disturbances in dialysis patients?

Suchergebnisse filtern